cloudfront

Report Detail



Other2018-2023 Global Paronychia Treatment Market Report (Status and Outlook)

  • RnM2475747
  • |
  • 29 August, 2018
  • |
  • Global
  • |
  • 116 pages
  • |
  • LPI(LP Information)
  • |
  • Other

2018-2023 Global Paronychia Treatment Market Report (Status and Outlook)

Table of Contents

    2018-2023 Global Paronychia Treatment Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Paronychia Treatment Market Size 2013-2023
        • 2.1.2 Paronychia Treatment Market Size CAGR by Region
      • 2.2 Paronychia Treatment Segment by Type
        • 2.2.1 Acute Paronychia
        • 2.2.2 Chronic Paronychia
        • 2.2.3 Candidal Paronychia
        • 2.2.4 Pyogenic Paronychia
      • 2.3 Paronychia Treatment Market Size by Type
        • 2.3.1 Global Paronychia Treatment Market Size Market Share by Type (2013-2018)
        • 2.3.2 Global Paronychia Treatment Market Size Growth Rate by Type (2013-2018)
      • 2.4 Paronychia Treatment Segment by Application
        • 2.4.1 Mupirocin Ointment
        • 2.4.2 Fusidic Acid Ointment
        • 2.4.3 Gentamicin Ointment
        • 2.4.4 Dicloxacillin
      • 2.5 Paronychia Treatment Market Size by Application
        • 2.5.1 Global Paronychia Treatment Market Size Market Share by Application (2013-2018)
        • 2.5.2 Global Paronychia Treatment Market Size Growth Rate by Application (2013-2018)

      3 Global Paronychia Treatment by Players

      • 3.1 Global Paronychia Treatment Market Size Market Share by Players
        • 3.1.1 Global Paronychia Treatment Market Size by Players (2016-2018)
        • 3.1.2 Global Paronychia Treatment Market Size Market Share by Players (2016-2018)
      • 3.2 Global Paronychia Treatment Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Paronychia Treatment by Regions

      • 4.1 Paronychia Treatment Market Size by Regions
      • 4.2 Americas Paronychia Treatment Market Size Growth
      • 4.3 APAC Paronychia Treatment Market Size Growth
      • 4.4 Europe Paronychia Treatment Market Size Growth
      • 4.5 Middle East & Africa Paronychia Treatment Market Size Growth

      5 Americas

      • 5.1 Americas Paronychia Treatment Market Size by Countries
      • 5.2 Americas Paronychia Treatment Market Size by Type
      • 5.3 Americas Paronychia Treatment Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Paronychia Treatment Market Size by Countries
      • 6.2 APAC Paronychia Treatment Market Size by Type
      • 6.3 APAC Paronychia Treatment Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Paronychia Treatment by Countries
      • 7.2 Europe Paronychia Treatment Market Size by Type
      • 7.3 Europe Paronychia Treatment Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Paronychia Treatment by Countries
      • 8.2 Middle East & Africa Paronychia Treatment Market Size by Type
      • 8.3 Middle East & Africa Paronychia Treatment Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Paronychia Treatment Market Forecast

      • 10.1 Global Paronychia Treatment Market Size Forecast (2018-2023)
      • 10.2 Global Paronychia Treatment Forecast by Regions
        • 10.2.1 Global Paronychia Treatment Forecast by Regions (2018-2023)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Paronychia Treatment Forecast by Type
      • 10.8 Global Paronychia Treatment Forecast by Application

      11 Key Players Analysis

      • 11.1 GlaxoSmithKline
        • 11.1.1 Company Details
        • 11.1.2 Paronychia Treatment Product Offered
        • 11.1.3 GlaxoSmithKline Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
        • 11.1.4 Main Business Overview
        • 11.1.5 GlaxoSmithKline News
      • 11.2 Glenmark Generics
        • 11.2.1 Company Details
        • 11.2.2 Paronychia Treatment Product Offered
        • 11.2.3 Glenmark Generics Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
        • 11.2.4 Main Business Overview
        • 11.2.5 Glenmark Generics News
      • 11.3 Teva Pharmaceutical Industries
        • 11.3.1 Company Details
        • 11.3.2 Paronychia Treatment Product Offered
        • 11.3.3 Teva Pharmaceutical Industries Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
        • 11.3.4 Main Business Overview
        • 11.3.5 Teva Pharmaceutical Industries News
      • 11.4 Eli Lilly
        • 11.4.1 Company Details
        • 11.4.2 Paronychia Treatment Product Offered
        • 11.4.3 Eli Lilly Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
        • 11.4.4 Main Business Overview
        • 11.4.5 Eli Lilly News
      • 11.5 Jonakayem Pharma Formulation
        • 11.5.1 Company Details
        • 11.5.2 Paronychia Treatment Product Offered
        • 11.5.3 Jonakayem Pharma Formulation Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
        • 11.5.4 Main Business Overview
        • 11.5.5 Jonakayem Pharma Formulation News
      • 11.6 Fougera Pharmaceuticals
        • 11.6.1 Company Details
        • 11.6.2 Paronychia Treatment Product Offered
        • 11.6.3 Fougera Pharmaceuticals Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
        • 11.6.4 Main Business Overview
        • 11.6.5 Fougera Pharmaceuticals News
      • 11.7 Taro Pharmaceutical Industries
        • 11.7.1 Company Details
        • 11.7.2 Paronychia Treatment Product Offered
        • 11.7.3 Taro Pharmaceutical Industries Paronychia Treatment Revenue, Gross Margin and Market Share (2016-2018)
        • 11.7.4 Main Business Overview
        • 11.7.5 Taro Pharmaceutical Industries News

      ...

        12 Research Findings and Conclusion

        In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Paronychia Treatment market for 2018-2023.

        Paronychia is a nail disease that is an often-tender bacterial or fungal infection of the hand or foot where the nail and skin meet at the side or the base of a finger or toenail. The infection can start suddenly (acute paronychia) or gradually (chronic paronychia).
        When no pus is present, warm soaks for acute paronychia is reasonable, even though there is a lack of evidence to support its use. Antibiotics such as clindamycin or cephalexin are also often used, the first being more effective in areas where MRSA is common. If there are signs of an abscess (the presence of pus) drainage is recommended. Chronic paronychia is treated by avoiding whatever is causing it, a topical antifungal, and a topical steroid. In those who do not improve following these measures oral antifungals and steroids may be used or the nail fold may be removed surgically.
        Over the next five years, LPI(LP Information) projects that Paronychia Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

        This report presents a comprehensive overview, market shares and growth opportunities of Paronychia Treatment market by product type, application, key companies and key regions.

        To calculate the market size, LP Information considers value generated from the sales of the following segments:

        Segmentation by product type:
        Acute Paronychia
        Chronic Paronychia
        Pyogenic Paronychia
        Segmentation by application:
        Mupirocin Ointment
        Fusidic Acid Ointment
        Gentamicin Ointment
        Dicloxacillin

        We can also provide the customized separate regional or country-level reports, for the following regions:
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
        GlaxoSmithKline
        Glenmark Generics
        Teva Pharmaceutical Industries
        Eli Lilly
        Jonakayem Pharma Formulation
        Fougera Pharmaceuticals
        Taro Pharmaceutical Industries
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Paronychia Treatment market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
        To understand the structure of Paronychia Treatment market by identifying its various subsegments.
        Focuses on the key global Paronychia Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Paronychia Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the size of Paronychia Treatment submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.




        Summary:
        Get latest Market Research Reports on Paronychia Treatment. Industry analysis & Market Report on Paronychia Treatment is a syndicated market report, published as 2018-2023 Global Paronychia Treatment Market Report (Status and Outlook). It is complete Research Study and Industry Analysis of Paronychia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $4,660.00
        $6,990.00
        $9,320.00
        3,129.19
        4,693.79
        6,258.38
        4,288.13
        6,432.20
        8,576.26
        564,512.40
        846,768.60
        1,129,024.80
        309,020.44
        463,530.67
        618,040.89
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report